Muraglitazar
Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα and PPARγ with EC50 of 320 nM and 110 nM respectively.
Product Specifications
CAS Number
331741-94-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
516.54
Molecular Formula
C29H28N2O7
Notes
Research use only, not for human use.
Receptor
PPAR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
